Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Voicehovska, G. Orlikov, A. Skesters, A. Ivanovs, A. Silova, I. Baidekalne, N. Voicehovskis, J. Karpovs, E. Maulins (Riga, Latvia). Selenium add-on therapy in bronchial asthma patients. Eur Respir J 2007; 30: Suppl. 51, 3604

Member's Comments

No comment yet.

Related content which might interest you: Advances of selenium add-on treatment in severe steroids-dependant bronchial asthma Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab Source: Eur Respir J, 52 (2) 1801025; 10.1183/13993003.01025-2018 Year: 2018 Efficacy of the long-term therapy with simbicort in children with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 395s Year: 2005 Neuroregulatorial therapy of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 55s Year: 2002 Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005 Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids Source: Breathe 2010; 6: 365 Year: 2010 Nebulized therapy in bronchial asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002 Inhaled antibiotic therapy in patients with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Montelukast as add-on therapy may improve some indices of small airways involvement in uncontrolled asthmatics Source: Annual Congress 2011 - Asthma management and response Year: 2011 Extracorporal therapy of bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 50s Year: 2001 Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 424s Year: 2001 Ciclesonide is effective in the treatment of bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001 Combined therapy of severe osteoporosis for patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 FENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma Source: Eur Respir J, 55 (5) 2001319; 10.1183/13993003.01319-2020 Year: 2020 Anti-IgE therapy with omalizumab decreases exacerbations in patients with poorly controlled moderate-to-severe allergic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 203s Year: 2003 Efficacy of symbicort administration in patients with bronchial asthma Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Sputum IL-1ß is reduced with Azithromycin add-on therapy in patients with poorly controlled asthma Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Effects of add-on treatment with budesonide/formoterol combination in eosinophilic COPD patients Source: International Congress 2017 – Management of COPD Year: 2017